2012
DOI: 10.1002/jsfa.5971
|View full text |Cite
|
Sign up to set email alerts
|

Sargassum polycystum reduces hyperglycaemia, dyslipidaemia and oxidative stress via increasing insulin sensitivity in a rat model of type 2 diabetes

Abstract: The consumption of either ethanolic or water extracts of S. polycystum dose dependently reduced dyslipidaemia in type 2 diabetic rats. S. polycystum is a potential insulin sensitiser, for a comestible complementary therapy in the management of type 2 diabetes which can help reduce atherogenic risk.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
41
1

Year Published

2014
2014
2022
2022

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(44 citation statements)
references
References 33 publications
2
41
1
Order By: Relevance
“…On the other hand, S. polycystum, a brown edible seaweed, exhibited moderate α-amylase inhibitory activity (46 %) which was in agreement with previous reports suggesting the anti-diabetic potential of this seaweed (Motshakeri et al 2013). Brown seaweeds are the most extensively studied marine algae for antidiabetic benefits.…”
Section: Discussionsupporting
confidence: 91%
“…On the other hand, S. polycystum, a brown edible seaweed, exhibited moderate α-amylase inhibitory activity (46 %) which was in agreement with previous reports suggesting the anti-diabetic potential of this seaweed (Motshakeri et al 2013). Brown seaweeds are the most extensively studied marine algae for antidiabetic benefits.…”
Section: Discussionsupporting
confidence: 91%
“…The phytochemicals and soluble fibres present in the extracts of S. polycystum have cholesterol-lowering effects and affect intestinal glucose absorption (Taskinen 2002;Vaugelade et al 2000). The aqueous extract of S. polycystum contains mostly sulphated polysaccharides, which can reduce hyperglycaemia, dyslipidaemia and oxidative stress by increasing insulin sensitivity in rat models of type 2 diabetes (Motshakeri et al 2013). Along with these reported studies, the present investigation adds strong supporting evidence that members of the species Sargassum (S. polycystum and S. wightii) are an excellent source of α-amylase, α-glucosidase and DPP-IV inhibitors.…”
Section: Discussionmentioning
confidence: 99%
“…In vivo studies and histopathological examinations are necessary to prove their efficacy and safety on the liver, kidney, pancreas, and the other important organs, since biochemical measurements alone are not conclusive. The common edible brown seaweed Sargassum polycystum ( C. Agardh ) (SP) reportedly alleviated hyperglycaemia and dislipidemia in diabetic rats [13], possibly due to its good antioxidant and free radical scavenging properties [14]. SP is reportedly used for eczema, scabies, and psoriasis, ulcer and lung diseases, renal dysfunction, viral hepatitis and heart ailments and to promote bile secretion [7], besides having antilipidemic, antioxidant and membrane stabilizing properties [8, 15].…”
Section: Introductionmentioning
confidence: 99%
“…It was reported to be hepatoprotective under high-fat/high-cholesterol diet [16]. The administration of SP ethanolic or water extracts dose dependently reduced blood glucose, glycosylated hemoglobin (HbA1C) levels, and dyslipidemia in type 2 diabetic animals [13]. SP appeared to be an insulin sensitizer, beneficial in the management of T2DM that can also help reduce atherogenic risk [13].…”
Section: Introductionmentioning
confidence: 99%